Loading...

Noxopharm Limited

NOX.AXASX
Healthcare
Biotechnology
A$0.12
A$-0.01(-4.00%)

Noxopharm Limited (NOX.AX) Financial Performance & Income Statement Overview

Review Noxopharm Limited’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.

Revenue Growth
-60.06%
60.06%
Operating Income Growth
54.59%
54.59%
Net Income Growth
76.24%
76.24%
Operating Cash Flow Growth
93.75%
93.75%
Operating Margin
-325.68%
325.68%
Gross Margin
-29.44%
29.44%
Net Profit Margin
-98.79%
98.79%
ROE
-47.18%
47.18%
ROIC
-175.31%
175.31%

Noxopharm Limited (NOX.AX) Income Statement & Financial Overview

Review Noxopharm Limited's (NOX.AX) income statement with detailed quarterly and annual figures.

MetricQ2 2025Q4 2024Q2 2024Q4 2023
Revenue$1.16M$1.19M$1.21M$2.66M
Cost of Revenue$1.55M$1.48M$876.00$11041.00
Gross Profit-$394530.00-$295752.00$1.21M$2.65M
Gross Profit Ratio-$0.34-$0.25$1.00$1.00
R&D Expenses$1.55M$1.48M$1.45M$4.85M
SG&A Expenses$1.86M$2.05M$2.02M$2.76M
Operating Expenses$3.41M$3.53M$3.47M$7.62M
Total Costs & Expenses$4.97M$5.01M$3.47M$7.63M
Interest Income$0.00$24.00$6906.00$18596.00
Interest Expense$0.00$4663.00$26497.00$33388.00
Depreciation & Amortization$879.00$867.00$876.00$11041.00
EBITDA-$2.26M-$2.34M-$3.68M-$12.25M
EBITDA Ratio-$1.95-$1.97-$3.04-$2.86
Operating Income-$3.81M-$3.83M-$3.47M-$7.63M
Operating Income Ratio-$3.29-$3.22-$2.86-$2.86
Other Income/Expenses (Net)$1.42M$1.56M-$1033.00-$2.43M
Income Before Tax-$2.39M-$2.27M-$3.71M-$12.29M
Income Before Tax Ratio-$2.07-$1.91-$3.06-$4.61
Income Tax Expense-$1.16M-$1.19M-$1.21M-$2.66M
Net Income-$1.24M-$1.08M-$2.50M-$9.63M
Net Income Ratio-$1.07-$0.91-$2.06-$3.61
EPS-$0.004-$0.004-$0.009-$0.03
Diluted EPS-$0.004-$0.004-$0.009-$0.03
Weighted Avg Shares Outstanding$292.29M$292.02M$292.24M$292.24M
Weighted Avg Shares Outstanding (Diluted)$292.24M$292.24M$292.24M$292.24M

Unlock 25+ Years of Financial Data

Get access to extended historical data, advanced metrics, and more with our premium plan

Frequently Asked Questions

;